Status:
COMPLETED
The Effects of Cognitive Remediation on Cognitive Function in Remitted Bipolar Disorder - a Proof of Concept Study
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
TrygFonden, Denmark
Copenhagen University Hospital, Hvidovre
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
Cognitive remediation (CR) is a new psychological treatment, which aims to improve cognitive function and coping skills. Several studies have recently demonstrated that CR improves cognitive and occup...
Eligibility Criteria
Inclusion
- Bipolar disorder in complete or partial remission (Hamilton Depression Rating Scale score of max 14 and Young Mania Scale score of max 14)
- Subjective complaints of moderate to severe cognitive problems on the Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire (CPFQ) (Fava et al 2006) (score at least 4 on at least 2 domains)
Exclusion
- Current ECT treatment
- Drug and/or alcohol abuse
- Schizophrenia
- Significant risk of suicide
- Use of benzodiazepines equivalent to more than 22,5 milligrams of Alopam
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2014
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT01457235
Start Date
August 1 2011
End Date
January 1 2014
Last Update
January 30 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Psychiatric Centre Copenhagen, Rigshospitalet, Denmark
Copenhagen, Denmark, 2100